Of note, albeit to some shared upregulated immunomodulatory molecules, abundant expression of cytokines (such as IL6, IL8), which is a hallmark of iCAFs in pancreatic and breast cancers26,27, was not observed in their counterparts of PTCs, suggesting heterogeneities in the iCAF-related regulatory mechanisms across different cancer types. Here, CXCL8 is linked to cancer.